Takeda

FDA grants priority review to Takeda’s BLA for dengue vaccine candidate
Pharmaceutical Business Review
Sat, 11/26/22 - 07:18 pm
Takeda
FDA
TAK-003
vaccines
dengue
Takeda touts positive first-line leukemia results — but isn't quite ready to reveal the hard data
Endpoints
Thu, 11/17/22 - 11:36 pm
Takeda
Ariad Pharmaceuticals
Iclusig
clinical trials
acute lymphoblastic leukemia
Seagen's highest selling drug snags a label expansion for pediatric cancer patients
Endpoints
Sun, 11/13/22 - 07:01 pm
Seagen
Takeda
Adcetris
Hodgkin's lymphoma
FDA
pediatric
If at first... pharma’s most drawn-out development timelines revealed
EP Vantage
Thu, 11/3/22 - 10:54 am
Kyowa Kirin
Takeda
Eiger BioPharmaceuticals
AstraZeneca
Teva Pharmaceutical
Bavarian Nordic
Halozyme
Novartis
MannKind
drug development
Takeda sues Apotex over prospective generic versions of its top leukemia drug
Endpoints
Thu, 10/20/22 - 11:33 pm
Takeda
Iclusig
generics
Apotex
Takeda adds one more late-stage treatment to its growing roster of celiac drugs
Endpoints
Thu, 10/20/22 - 10:39 am
Takeda
celiac disease
ZED1227
TAK-227
Zedira
Few safe havens surface in another down quarter for biopharma
EP Vantage
Fri, 10/14/22 - 10:03 am
biopharma stocks
COVID-19
Eli Lilly
Bristol Myers Squibb
Merck
Daiichi Sankyo
Vertex Pharmaceuticals
Takeda
Neurocrine
Sarepta Therapeutics
Orion
Pfizer
GSK
Roche
Moderna Therapeutics
BeiGene
BioNTech
Novavax
CureVac
Takeda to stop making parathyroid drug Natpara in 2024 after production challenges
BioPharma Dive
Tue, 10/4/22 - 11:40 pm
Takeda
Natpara
drug manufacturing
hypoparathyroidism
Biotech’s near-term key catalysts
EP Vantage
Thu, 09/29/22 - 09:45 am
Biogen
Eisai
Alzheimer's disease
Arrowhead Pharmaceuticals
Takeda
RNAi
Madrigal
NASH
Ascendis
FDA
MHRA raises concerns with switching between long-acting J&J, Novartis and Takeda ADHD drugs
Fierce Pharma
Tue, 09/27/22 - 10:37 am
Takeda
JNJ
Novartis
ADHD
MHRA
Concerta XL
Ritalin XL
Equasym XL
Puma pounces on failed Takeda drug, snapping up cancer prospect for knockdown price
Fierce Biotech
Wed, 09/21/22 - 10:17 am
Puma Biotechnology
Takeda
Aurora A/angiogenic kinase inhibitor
clinical trials
Alisertib
Takeda’s manufacturing site in Belgium gets a €300M boost for plasma therapy production
Endpoints
Wed, 09/14/22 - 07:54 pm
Takeda
R&D
drug manufacturing
Belgium
Plasma Therapeutics
One week after Takeda walked away, Finch faces second round of layoffs, pipeline pruning
Endpoints
Thu, 09/1/22 - 10:45 am
Finch Therapeutics
Takeda
layoffs
C. difficile
Finch Therapeutics Regains Rights to Two Takeda-Owned IBD Drugs
BioSpace
Fri, 08/26/22 - 10:41 am
Takeda
Finch Therapeutics
FIN-524
FIN-525
inflammatory bowel disease
Revealed: which pharma companies leading the way in artificial intelligence
Clinical Trials Arena
Fri, 08/26/22 - 10:37 am
artificial intelligence
Pfizer
Novartis
AstraZeneca
Johnson & Johnson
Bristol Myers Squibb
Takeda
GSK
Bayer
Astellas
Years after Sanofi's Dengvaxia fiasco, Takeda lands first OK for its own dengue vaccine
Endpoints
Tue, 08/23/22 - 10:27 am
Takeda
dengue
vaccines
WHO
TAK-003
Qdenga
Indonesia
Flush with $126M raise, Tessa Therapeutics woos new CEO from Takeda
Endpoints
Mon, 08/22/22 - 10:04 am
Tessa Therapeutics
Takeda
Thomas Willemsen
CAR-T
Pharma CEOs
Takeda cuts ties to cancer drug landed in $120M Turnstone deal
Fierce Biotech
Thu, 07/28/22 - 10:59 am
Takeda
narcolepsy
TAK-994
TAK-605
Turnstone Biologics
A year after netting Takeda partnership, small molecule startup arms itself with some new cash
Endpoints
Wed, 07/27/22 - 10:52 am
startups
BridGene Biosciences
Takeda
funding
Eli Lilly
Ascletis, Takeda, Arrowhead & More Present New Findings at EASL Liver Conference
BioSpace
Tue, 06/28/22 - 10:49 am
EASL
liver disease
Ascletis
Takeda
Arrowhead Pharmaceuticals

Pages